Medicine and Dentistry
Patient
100%
Chimeric Antigen Receptor T-Cell
75%
Cancer Immunotherapy
75%
Acute B-Cell Lymphoblastic Leukemia
75%
Adult
75%
Pediatrics
75%
Donor
75%
Side Effect
50%
Cell Therapy
50%
Therapeutic Procedure
30%
Chimeric Antigen Receptor T-Cell Therapy
25%
Antineoplastic Activity
25%
Brain Disease
25%
Medical Specialty
25%
Cytokine Release Syndrome
25%
Clinical Trial
25%
Syndrome
25%
Complication
25%
Hematologic Malignancy
25%
T Cell
25%
Intensive Care
25%
Hematopoietic Stem Cell Transplantation
25%
Child
23%
Infusion
11%
Pulmonary Hemorrhage
5%
Progressive Disease
5%
Chimeric Antigen Receptor T-Cell Immunotherapy
5%
Immunology and Microbiology
B Cell
75%
Chimeric Antigen Receptor T-Cell Therapy
15%
Stem Cell Transplant
15%
Graft-Versus-Host Disease
15%
Pharmacology, Toxicology and Pharmaceutical Science
Antileukemic Agent
50%
Clinical Trial
12%
Leukemia
12%
Neurotoxicity
12%
Graft Versus Host Reaction
12%
